Eternity in Medical Information -- Medisurf
Items 1 ~ 8 of 8, Page 1 of 1
Merck Begins Rolling Submission of Licensure Application for V920 (rVSV G-ZEBOV-GP) to U.S. Food and Drug Administration
V920 is the Company's Investigational Vaccine for Ebola Zaire
11.13.2018 MERCK
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus).
11.09.2018 U.S. FOOD & DRUG ADMINISTRATION
Flu mutations in a single cell help to predict immune response
Genetic diversity of the virus may explain variability in how well a cell fights back.
10.26.2018 Nature News by Carrie Arnold
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
ABBOTT PARK, Ill., Oct. 25, 2018 /PRNewswire/ Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has cleared its next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing1,2. These new assays enable the fastest-ever3 time to molecular influenza A & B and Strep A results at the point of care.4 Currently available on the ID NOW™ platform (formerly Alere i), both assays have been granted a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
10.25.2018 Abbott
Flu vaccine reduces risk of flu hospitalization among pregnant women
Over the course of six flu seasons, getting a flu shot reduced a pregnant woman"s risk of being hospitalized from flu by an average of 40 percent.
10.11.2018 Centers for Disease Control and Prevention (CDC)
Relatives of Zika Virus Could Infect Fetal Tissue
Emerging viruses already circulating in the Western Hemisphere could infect fetal tissue and might have the capacity to cause birth defects, according to preclinical findings published January 31 in Science Translational Medicine.
01.30.2018 AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS)
Mutated, Defenseless Virus Could Lead to Universal Flu Vaccine
The unpredictability of seasonal influenza has researchers looking for a "universal" vaccine against all strains of the virus. | Flickr/ peigov / CC BY-NC-ND 2.0 ] A mutant influenza A virus generated by scientists at the University of California, Los Angeles...
01.18.2018 AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS)
Influenza Leads to Increased Missed Work Time
Compared to Non-Influenza Illness, Flu Causes More Productivity Loss
12.07.2017 American College of Occupational and Environmental Medicine (ACOEM)
   
1